Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Targeted therapy in EGFR-mutated lung cancer following chemoradiotherapy].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] - 1 Oct 2024

Müller Jörg Andreas, Vordermark Dirk

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung
Share to Chemoradiotherapy
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Molecular Targeted Therapy

Share to Mutation

Source

Identifiers

PMID: 39095648
DOI: 10.1007/s00066-024-02284-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Targeted therapy in EGFR-mutated lung cancer following chemoradiotherapy].PMID 39095648Read ↗

[Responses to targeted therapies: lung cancer].Semantic proximity Read ↗

[Acquired resistance mechanisms to EGFR-TKIs in EGFR mutated lung cancers].Semantic proximity Read ↗

Targeted therapies in lung cancer.Semantic proximity Read ↗

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.Semantic proximity Read ↗

Targeted therapy in BRAF-mutated lung adenocarcinoma.Semantic proximity Read ↗

Adjuvant Targeted Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer.Semantic proximity Read ↗

[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 3. Chemotherapy for patients with non-small cell lung cancer, 2) Driver mutation and molecular-targeted therapy in lung cancer].Semantic proximity Read ↗

[Targeted therapies in the treatment of non-small cell lung cancer].Semantic proximity Read ↗

Targeted therapy in lung cancer: survival, quality of life improved for some patients.Semantic proximity Read ↗

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].Semantic proximity Read ↗

Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors.Semantic proximity Read ↗

[New biological treatments for lung cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.